Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, November 13, 2015 11:20:07 AM
bearish 7.60
## source: finance.yahoo.com
Tue, 10 Nov 2015 00:19:53 GMT ~ Agile Therapeutics reports 3Q loss
read full: http://sg.finance.yahoo.com/news/agile-therapeutics-reports-3q-loss-001953555.html
*********************************************************
Tue, 10 Nov 2015 00:19:53 GMT ~ Agile Therapeutics reports 3Q loss
read full: http://finance.yahoo.com/news/agile-therapeutics-reports-3q-loss-001953268.html
*********************************************************
Mon, 09 Nov 2015 21:22:21 GMT ~ AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
read full: http://biz.yahoo.com/e/151109/agrx8-k.html
*********************************************************
Mon, 09 Nov 2015 21:16:19 GMT ~ Agile Therapeutics Reports Third Quarter Financial Results
[at noodls] - Agile Therapeutics Reports Third Quarter Financial Results
read full: http://www.noodls.com/view/3D13681DDF8F396E250BF85989B013A63D5AC0AB
*********************************************************
Mon, 09 Nov 2015 21:10:00 GMT ~ Agile Therapeutics Reports Third Quarter Financial Results
[GlobeNewswire] - PRINCETON, N.J., Nov. 09, 2015-- Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, ...
read full: http://finance.yahoo.com/news/agile-therapeutics-reports-third-quarter-211000855.html
*********************************************************
$AGRX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AGRX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AGRX/company-info
Ticker: $AGRX
OTC Market Place: Not Available
CIK code: not found
Company name: Agile Therapeutics, Inc.
Incorporated In:
$AGRX share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AGRX extra dd links
Company name: Agile Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AGRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AGRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AGRX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AGRX/news - http://finance.yahoo.com/q/h?s=AGRX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AGRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AGRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AGRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AGRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Agile+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Agile+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Agile+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AGRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AGRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AGRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AGRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AGRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AGRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AGRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AGRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AGRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AGRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AGRX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AGRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AGRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AGRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AGRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AGRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AGRX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AGRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AGRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AGRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AGRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AGRX
$AGRX DD Notes ~ http://www.ddnotesmaker.com/AGRX
Recent AGRX News
- Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/28/2024 12:05:00 PM
- Agile Therapeutics Announces Delisting from Nasdaq • GlobeNewswire Inc. • 03/25/2024 08:30:00 PM
- Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024 • GlobeNewswire Inc. • 03/21/2024 10:35:00 AM
- Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024 • GlobeNewswire Inc. • 03/20/2024 12:15:00 PM
- Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution • GlobeNewswire Inc. • 03/13/2024 11:31:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 09:57:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 09:55:25 PM
- Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds • GlobeNewswire Inc. • 02/22/2024 02:01:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:30 PM
- Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update • GlobeNewswire Inc. • 02/15/2024 09:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:02:00 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/07/2024 09:51:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:14:35 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/05/2024 02:21:25 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/02/2024 09:27:13 PM
- The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost • GlobeNewswire Inc. • 01/23/2024 02:29:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/20/2023 01:00:42 PM
- Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement • GlobeNewswire Inc. • 12/12/2023 01:01:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/11/2023 10:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 01:00:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:15:21 PM
- Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/09/2023 01:05:00 PM
- Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023 • GlobeNewswire Inc. • 10/26/2023 12:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM